130 related articles for article (PubMed ID: 2973852)
1. [Sulodexide treatment approach in patients with atherosclerotic vascular disease with various localizations].
Capone-Braga M; Tellini L; Boncompagni L; Bettoni M; Burali A; Bensi A
Clin Ter; 1987 Jan; 120(1):25-31. PubMed ID: 2973852
[No Abstract] [Full Text] [Related]
2. [Sulodexide in the therapy of vasculopathies].
Postiglione F; Pisani P; Gisonni P; Perrotta P; Gisonni A; Canciello M; Napolitano L; Brighina G; Ragno I; Salzano A
Clin Ter; 1986 May; 117(3):223-31. PubMed ID: 3524974
[No Abstract] [Full Text] [Related]
3. Preliminary results of sulodexide treatment in patients with peripheral arteriosclerosis and hyperlipidemia. A multicentre trial.
Crepaldi G; Fellin R; Calabrò A; Baiocchi MR; Rossi A; Lenzi S; Descovich GC; Delmonte G; Gaddi A; Ventura A
Monogr Atheroscler; 1986; 14():215-21. PubMed ID: 3526129
[No Abstract] [Full Text] [Related]
4. [The use of glucuronyl-glucosamino-glycan sulfate (3GS) in the treatment of cerebral and peripheral athero-arteriosclerotic pathology].
Ciammaichella A; Solitro A; Torcia L; Arcuri P
Clin Ter; 1978 Mar; 84(5):509-21. PubMed ID: 648104
[No Abstract] [Full Text] [Related]
5. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)].
Turpini R; Caliandro L; Cocchi A; Volpi F; Brusaioli G; Grignani G; Antognetti R
Clin Ter; 1975 May; 73(3):213-36. PubMed ID: 123842
[No Abstract] [Full Text] [Related]
6. [Glucuronyl-glucosaminoglycan sulfate in therapy of atheroarteriosclerotic syndromes in geriatrics].
Bompani R; Violi G
Minerva Med; 1974 Nov; 65(83):4315-29. PubMed ID: 4279362
[No Abstract] [Full Text] [Related]
7. [The significance of sulodexide in the prevention of obliterative atherosclerotic arterial disease of the lower limbs].
Martino R; Benini D
Clin Ter; 1985 Mar; 112(5):429-37. PubMed ID: 4017468
[No Abstract] [Full Text] [Related]
8. [Rapid effect of glucuronyl glucosamine glycan sulfate on the blood levels of HDL-cholesterol in vascular diseases].
Ferlito S; La Spina E; Cultrera E; Puleo F; Carrà G
Arch Sci Med (Torino); 1982; 139(2):175-81. PubMed ID: 7138283
[TBL] [Abstract][Full Text] [Related]
9. [Experience with sulodexide (Vessel Due F) in diabetics with ischemic disease of the lower extremities].
Utratová J; Mayer J; Elbl L; Vorlícek J; Prásek J
Vnitr Lek; 1993 Jun; 39(6):575-80. PubMed ID: 8212613
[TBL] [Abstract][Full Text] [Related]
10. [Clinical experiences on the anti-dyslipidemic effect of a new sulfomucopolysaccharide of pancreatic origin].
Castello S
Clin Ter; 1971 Aug; 58(4):323-34. PubMed ID: 4258171
[No Abstract] [Full Text] [Related]
11. [Treatment of atherosclerosis with hypolipidemic and antiuricemic agents].
Plastinina RA; Oleĭnik NA; Valeeva RM; Pavlova TN
Sov Med; 1984; (1):83-7. PubMed ID: 6701660
[No Abstract] [Full Text] [Related]
12. [Antilipemic and coronary-active treatment of arteriosclerosis: clinical experience].
Poggio R; Velle G
Clin Ter; 1978 Jul; 86(2):129-35. PubMed ID: 743855
[No Abstract] [Full Text] [Related]
13. [The clofibrate-dipyridamole combination in the prevention and therapy of arteriosclerotic vascular disease and its complications].
Cucinotta D; Ferretti PG; Daccò L; Mazzera F
G Clin Med; 1977; 58(11-12):475-86. PubMed ID: 608558
[No Abstract] [Full Text] [Related]
14. [Anginin in the treatment of coronary artery disease].
Markiewicz M; Korolko A; Jaroszyński G
Pol Tyg Lek; 1973 Jun; 28(23):871-3. PubMed ID: 4720261
[No Abstract] [Full Text] [Related]
15. Effectiveness of short-term sulodexide treatment on peripheral vascular disease clinical manifestations.
Caramelli L; Mirchioni R; Carini A
Riv Eur Sci Med Farmacol; 1988 Feb; 10(1):55-8. PubMed ID: 3079198
[No Abstract] [Full Text] [Related]
16. [Effect of sulodexide on hemorheological parameters in a group of patients with peripheral arteriosclerotic vascular disease].
Calabrò A; Rossi A; Baiocchi MR; Coscetti G; Fellin R; Crepaldi G
Ric Clin Lab; 1985; 15 Suppl 1():455-63. PubMed ID: 4035227
[TBL] [Abstract][Full Text] [Related]
17. [The heparin tolerance test in the treatment of regional and diffuse atherosclerotic vascular diseases].
Guglielmi G; Barlattani M
Clin Ter; 1971 Aug; 58(3):229-42. PubMed ID: 5135002
[No Abstract] [Full Text] [Related]
18. [Therapy of arteriosclerotic vasculopathies with arterial wall extract].
Veccia F
Clin Ter; 1967 Sep; 42(5):429-42. PubMed ID: 5617689
[No Abstract] [Full Text] [Related]
19. [Clinical evaluation of a fribrinolytic drug in an experimental cross-over study].
Bizzi B; Butti A
Minerva Med; 1969 Dec; 60(99 Suppl):5062-7. PubMed ID: 4188590
[No Abstract] [Full Text] [Related]
20. [Electroencephalographic findings in a group of aged subjects treated with potentiated gerovital-H3].
Aslan A; Buşilă V; Sacerdoţeanu F
Fiziol Norm Patol; 1968; 14(3):263-70. PubMed ID: 5686658
[No Abstract] [Full Text] [Related]
[Next] [New Search]
